dbmi-pitt / DIKB-Micropublication

Micropublication and Open Data Annotation for drug-drug interaction evidence synthesis
Apache License 2.0
7 stars 1 forks source link

Do we want ALL possible materials to be annotated separately? #42

Open jodischneider opened 8 years ago

jodischneider commented 8 years ago

Modeling decision. Do we want ALL possible materials? Which are relevant to the evidence board?

screen shot 2015-08-06 at 10 36 36 am

Currently we have a single Material, which mentions the two main drugs of interest, e.g.:

<owl:NamedIndividual rdf:about="http://dbmi-icode-01.dbmi.pitt.edu/mp/ddi-spl-annotation-material-66">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu/dikb-evidence/DIKB_evidence_ontology_v1.3.owl#EV_PK_DDI_RCT_Material"/>
    <rdf:type rdf:resource="&mp;Material"/>
    <rdfs:label>SIMVASTATIN (object) - ERYTHROMYCIN (precipitant)</rdfs:label>
    <resource:precipitantDose>0.5</resource:precipitantDose>
    <resource:objectDose>0.04</resource:objectDose>
    <resource:numOfSubjects>12</resource:numOfSubjects>
    <mp:usedIn rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu/mp/ddi-spl-annotation-method-66"/>
    <resource:ObjectDrugOfInteraction rdf:resource="http://purl.obolibrary.org/obo/CHEBI_48923"/>
    <resource:PrecipitantDrugOfInteraction rdf:resource="http://purl.obolibrary.org/obo/CHEBI_9150"/>
</owl:NamedIndividual>
jodischneider commented 8 years ago

One material.

Properties depend on the Method type associated with the Method. Properties could be, e.g. population, demographics, precipitant, object, comparator (similar to PICO). These are specified when the plugins are built.